Solution NMR studies of Aβ monomer dynamics

Protein and Peptide Letters

Volumn 18, Issue 4, 2011, Pages 354-361

  Wang, Chunyu ^a  

^a Research Rensselaer Polytechnic Institute   (United States)

Author keywords

Aggregation; Alzheimer's disease; Amyloid peptide; Dynamics; M35 oxidation; Solution NMR

Indexed keywords

AMYLOID BETA PROTEIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; SOLUTION AND SOLUBILITY;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; HUMANS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; SOLUTIONS;

EID: 79951666409     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986611794653969     Document Type: Article

References (42)

1. Hardy, J. Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J. Alzheimers Dis., 2006, 9, 151-153. (Pubitemid 44253307)
2. Hardy, J. Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr. Alzheimer Res., 2006, 3, 71-73.
3. Hardy, J. A.; Higgins, G. A. Alzheimer's disease: the amyloid cascade hypothesis. Science, 1992, 256, 184-185.
4. Walsh, D. M.; Lomakin, A.; Benedek, G. B.; Condron, M. M.; Teplow, D. B. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem., 1997, 272, 22364-22372. (Pubitemid 27382873)
5. Walsh, D. M.; Selkoe, D. J. A beta oligomers-a decade of discovery. J. Neurochem., 2007, 101, 1172-1184.
6. Kayed, R.; Head, E.; Thompson, J. L.; McIntire, T. M.; Milton, S. C.; Cotman, C. W.; Glabe, C. G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 2003, 300, 486-489. (Pubitemid 36444329)
7. Lesne, S.; Koh, M. T.; Kotilinek, L.; Kayed, R.; Glabe, C. G.; Yang, A.; Gallagher, M.; Ashe, K. H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature, 2006, 440, 352-357.
8. Oddo, S.; Caccamo, A.; Tran, L.; Lambert, M. P.; Glabe, C. G.; Klein, W. L.; LaFerla, F. M. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J. Biol. Chem., 2006, 281, 1599-1604.
9. Shankar, G. M.; Li, S.; Mehta, T. H.; Garcia-Munoz, A.; Shepardson, N. E.; Smith, I.; Brett, F. M.; Farrell, M. A.; Rowan, M. J.; Lemere, C. A.; Regan, C. M.; Walsh, D. M.; Sabatini, B. L.; Selkoe, D. J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med., 2008, 14, 837-842.
10. Cleary, J. P.; Walsh, D. M.; Hofmeister, J. J.; Shankar, G. M.; Kuskowski, M. A.; Selkoe, D. J.; Ashe, K. H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci., 2005, 8, 79-84. (Pubitemid 41236735)
11. Haass, C.; Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid betapeptide. Nat. Rev. Mol. Cell Biol., 2007, 8, 101-112. (Pubitemid 46432529)
12. Lorenzo, A.; Yankner, B. A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red,. Proc. Natl. Acad. Sci. U S A, 1994, 91, 12243-12247. (Pubitemid 24368641)
13. Walsh, D. M.; Hartley, D. M.; Kusumoto, Y.; Fezoui, Y.; Condron, M. M.; Lomakin, A.; Benedek, G. B.; Selkoe, D. J.; Teplow, D. B. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem., 1999, 274, 25945-25952.
14. Meyer-Luehmann, M.; Spires-Jones, T. L.; Prada, C.; Garcia-Alloza, M.; de Calignon, A.; Rozkalne, A.; Koenigsknecht-Talboo, J.; Holtzman, D. M.; Bacskai, B. J.; Hyman, B. T. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature, 2008, 451, 720-724. (Pubitemid 351220570)
15. Yan, P.; Bero, A. W.; Cirrito, J. R.; Xiao, Q.; Hu, X.; Wang, Y.; Gonzales, E.; Holtzman, D. M.; Lee, J. M. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. J. Neurosci., 2009, 29, 10706-10714.
16. Hou, L.; Shao, H.; Zhang, Y.; Li, H.; Menon, N. K.; Neuhaus, E. B.; Brewer, J. M.; Byeon, I. J.; Ray, D. G.; Vitek, M. P.; Iwashita, T.; Makula, R. A.; Przybyla, A. B.; Zagorski, M. G. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J. Am. Chem. Soc., 2004, 126, 1992-2005. (Pubitemid 38228879)
17. Bitan, G.; Teplow, D. B. Preparation of aggregate-free, low molecular weight amyloid-beta for assembly and toxicity assays. Methods Mol. Biol., 2005, 299, 3-9.
18. Danielsson, J.; Jarvet, J.; Damberg, P.; Graslund, A. Translational diffusion measured by PFG-NMR on full length and fragments of the Alzheimer A beta(1-40) peptide. Determination of hydrodynamic radii of random coil peptides of varying length. Magn. Reson. Chem., 2002, 40, S89-S97. (Pubitemid 37296918)
19. Hou, L.; Kang, I.; Marchant, R. E.; Zagorski, M. G. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J. Biol. Chem., 2002, 277, 40173-40176. (Pubitemid 35215584)
20. Brath, U.; Akke, M.; Yang, D.; Kay, L. E.; Mulder, F. A. Functional dynamics of human FKBP12 revealed by methyl 13C rotating frame relaxation dispersion NMR spectroscopy. J. Am. Chem. Soc., 2006, 128, 5718-5727. (Pubitemid 43724374)
21. Yan, Y.; Wang, C. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity. J. Mol. Biol., 2006, 364, 853-862. (Pubitemid 44765041)
22. Farrow, N. A.; Muhandiram, R.; Singer, A. U.; Pascal, S. M.; Kay, C. M.; Gish, G.; Shoelson, S. E.; Pawson, T.; Forman-Kay, J. D.; Kay, L. E. Backbone dynamics of a free and phosphopeptidecomplexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry, 1994, 33, 5984-6003. (Pubitemid 24184605)
23. Altieri, A. S.; Hinton, D. P.; Byrd, R. A. Association Of Biomolecular Systems Via Pulsed-Field Gradient Nmr Self-Diffusion Measurements. J. Am. Chem. Soc., 1995, 117, 7566-7567.
24. Lipari, G.; Szabo, A. Model-Free Approach To The Interpretation Of Nuclear Magnetic-Resonance Relaxation In Macromolecules .1. Theory And Range Of Validity. J. Am. Chem. Soc., 1982, 104, 4546-4559.
25. Lipari, G.; Szabo, A. Model-Free Approach To The Interpretation Of Nuclear Magnetic-Resonance Relaxation In Macromolecules .2. Analysis Of Experimental Results. J. Am. Chem. Soc., 1982, 104, 4559-4570.
26. Massi, F.; Peng, J. W.; Lee, J. P.; Straub, J. E. Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. Biophys. J., 2001, 80, 31-44.
27. Zhang, S.; Iwata, K.; Lachenmann, M. J.; Peng, J. W.; Li, S.; Stimson, E. R.; Lu, Y.; Felix, A. M.; Maggio, J. E.; Lee, J. P. The Alzheimer's peptide a beta adopts a collapsed coil structure in water. J. Struct. Biol., 2000, 130, 130-141.
28. Watanabe, H.; Fujiyama, A.; Hattori, M.; Taylor, T. D.; Toyoda, A.; Kuroki, Y.; Noguchi, H.; BenKahla, A.; Lehrach, H.; Sudbrak, R.; Kube, M.; Taenzer, S.; Galgoczy, P.; Platzer, M.; Scharfe, M.; Nordsiek, G.; Blocker, H.; Hellmann, I.; Khaitovich, P.; Paabo, S.; Reinhardt, R.; Zheng, H. J.; Zhang, X. L.; Zhu, G. F.; Wang, B. F.; Fu, G.; Ren, S. X.; Zhao, G. P.; Chen, Z.; Lee, Y. S.; Cheong, J. E.; Choi, S. H.; Wu, K. M.; Liu, T. T.; Hsiao, K. J.; Tsai, S. F.; Kim, C. G.; S, O. O.; Kitano, T.; Kohara, Y.; Saitou, N.; Park, H. S.; Wang, S. Y.; Yaspo, M. L.; Sakaki, Y. DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature, 2004, 429, 382-388.
29. Houben, K.; Boelens, R. Side chain dynamics monitored by 13C-13C cross-relaxation. J. Biomol. NMR, 2004, 29, 151-166. (Pubitemid 38444477)
30. Lee, A. L.; Kinnear, S. A.; Wand, A. J. Redistribution and loss of side chain entropy upon formation of a calmodulin-peptide complex. Nat. Struct. Biol., 2000, 7, 72-77. (Pubitemid 30043252)
31. Ishima, R.; Torchia, D. A. Protein dynamics from NMR. Nat. Struct. Biol., 2000, 7, 740-743.
32. Kim, W.; Hecht, M. H. Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40. J. Biol. Chem., 2005, 280, 35069-35076. (Pubitemid 41504642)
33. Zhang, X.; Sui, X.; Yang, D. Probing methyl dynamics from 13C autocorrelated and cross-correlated relaxation. J. Am. Chem. Soc., 2006, 128, 5073-5081.
34. Yan, Y., Liu, J.; McCallum, S. A.; Yang, D.; Wang, C. Methyl dynamics of the amyloid-beta peptides Abeta40 and Abeta42. Biochem. Biophys. Res. Commun., 2007, 362, 410-414. (Pubitemid 47334922)
35. Sgourakis, N. G.; Yan, Y.; McCallum, S. A.; Wang, C.; Garcia, A. E. The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study. J. Mol. Biol., 2007, 368, 1448-1457. (Pubitemid 46617600)
36. Soto, C.; Castano, E. M.; Frangione, B.; Inestrosa, N. C. The alphahelical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J. Biol. Chem., 1995, 270, 3063-3067.
37. Christopeit, T.; Hortschansky, P.; Schroeckh, V.; Guhrs, K.; Zandomeneghi, G.; Fandrich, M. Mutagenic analysis of the nucleation propensity of oxidized Alzheimer's beta-amyloid peptide. Protein Sci., 2005, 14, 2125-2131. (Pubitemid 41132378)
38. Chen, Y. R.; Glabe, C. G. Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. J. Biol. Chem., 2006, 281, 24414-24422. (Pubitemid 44274214)
39. Kuo, Y. M.; Kokjohn, T. A.; Beach, T. G.; Sue, L. I.; Brune, D.; Lopez, J. C.; Kalback, W. M.; Abramowski, D.; Sturchler-Pierrat, C.; Staufenbiel, M.; Roher, A. E. Comparative analysis of amyloidbeta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains . J. Biol. Chem., 2001, 276, 12991-12998.
40. Bitan, G.; Kirkitadze, M. D.; Lomakin, A.; Vollers, S. S.; Benedek, G. B.; Teplow, D. B. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U S A, 2003, 100, 330-335. (Pubitemid 36078074)
41. Bernstein, S. L.; Dupuis, N. F.; Lazo, N. D.; Wyttenbach, T.; Condron, M. M.; Bitan, G.; Teplow, D. B.; Shea, J.-E.; Ruotolo, B. T.; Robinson, C. V.; Bowers, M. T. Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat. Chem., 2009, 1, 326-331.
42. Yan, Y.; McCallum, S. A.; Wang, C. M35 oxidation induces Abeta40-like structural and dynamical changes in Abeta42. J. Am. Chem. Soc., 2008, 130, 5394-5395. (Pubitemid 351612926)